全文获取类型
收费全文 | 843篇 |
免费 | 52篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 19篇 |
妇产科学 | 2篇 |
基础医学 | 110篇 |
口腔科学 | 35篇 |
临床医学 | 41篇 |
内科学 | 274篇 |
皮肤病学 | 16篇 |
神经病学 | 54篇 |
特种医学 | 25篇 |
外科学 | 99篇 |
综合类 | 2篇 |
预防医学 | 39篇 |
眼科学 | 6篇 |
药学 | 60篇 |
中国医学 | 11篇 |
肿瘤学 | 100篇 |
出版年
2024年 | 1篇 |
2023年 | 4篇 |
2022年 | 17篇 |
2021年 | 14篇 |
2020年 | 20篇 |
2019年 | 23篇 |
2018年 | 16篇 |
2017年 | 18篇 |
2016年 | 24篇 |
2015年 | 29篇 |
2014年 | 34篇 |
2013年 | 31篇 |
2012年 | 57篇 |
2011年 | 64篇 |
2010年 | 31篇 |
2009年 | 39篇 |
2008年 | 56篇 |
2007年 | 72篇 |
2006年 | 56篇 |
2005年 | 62篇 |
2004年 | 62篇 |
2003年 | 36篇 |
2002年 | 48篇 |
2001年 | 8篇 |
2000年 | 3篇 |
1999年 | 11篇 |
1998年 | 10篇 |
1997年 | 4篇 |
1996年 | 4篇 |
1995年 | 5篇 |
1994年 | 5篇 |
1993年 | 6篇 |
1992年 | 3篇 |
1991年 | 3篇 |
1990年 | 2篇 |
1989年 | 3篇 |
1988年 | 2篇 |
1987年 | 3篇 |
1986年 | 2篇 |
1985年 | 1篇 |
1983年 | 2篇 |
1980年 | 2篇 |
1977年 | 2篇 |
1976年 | 2篇 |
1974年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有899条查询结果,搜索用时 15 毫秒
1.
Osamu Tochikubo Naoki Kura Hiroko Tokita Seiko Sakon Kiyoko Nishijima 《Hypertension research》2006,29(4):233-241
Direct measurement of intra-arterial blood pressure (BP) for 24-h provides approximately 100,000 values that vary enormously, but each (BPi) can be expressed by the equation BPi = BP0 + DeltaBPi (BP0, base BP; DeltaBPi, BP increment, i=1, 2, ..., 100 x 10(3)). About 20% of outpatients with hypertension exhibit white-coat hypertension (WCH). In such patients, DeltaBPc (i = c; c, time at the clinic) is surmised to be large. A method for explaining the physiological factors in DeltaBPc and the estimation of base BP in the outpatient clinic is important. This study addresses this issue. A total of 293 subjects were divided into four groups: 1) WCH group, 45 individuals (office BP > or = 140/90 mmHg and 24-h indirect BP < 125/80 mmHg); 2) normotensive (NT) group, 84 controls matched for age and sex; 3) WHO-I group, 95 hypertensive patients with WHO stage I (office BP > or = 140/90 mmHg and 24-h BP > or = 125/80 mmHg); and 4) WHO-II group, 69 hypertensive patients with WHO stage II. Their BPc and heart rate (HR; HRc, clinic HR) values were measured by a BP-ECG monitoring device in the outpatient clinic. Power-spectral analysis was used to obtain the ratio between the low-frequency component (LF) and high-frequency component (HF) of ECG-RR variability (LF/HF = LH). Twenty-four-hour indirect BP (and BP0) and base HR (HR0) were measured by a portable device (TM2425) at 30-min intervals. Then, DeltaBPc (= BPc - BP0) was estimated by performing linear multivariate analysis applying the model equation DeltaBPc = (BPc -alphaLH)(1-betaHR0/HRc) + epsilon to the above variables (alpha and beta, constant values; epsilon, error). This model equation made it possible to estimate BP0 (and DeltaBPc) with a high coefficient of correlation (r > or = 0.85, mean of error less than 0.82 +/- 5.9 mmHg). The predictive accuracy for discrimination between WCH and sustained hypertension (WHO-I and WHO-II groups) by this equation was 88%. The new DeltaBP-estimation device (BP-ECG monitor) enabled us to infer BP0 and is therefore useful in estimating WCH in the outpatient clinic. 相似文献
2.
Keisuke Morita MD ; Kazunori Urabe ; Yoichi Moroi ; Tetsuya Koga ; Ryuji Nagai ; Seiko Horiuchi ; Masutaka Furue 《Wound repair and regeneration》2005,13(1):93-101
Advanced glycation end products are the chemical modification of proteins induced by sugars in a hyperglycemic condition. Extracellular matrix proteins are prominent targets of nonenzymatic glycation because of their slow turnover rates. The aim of this study was to investigate the influence of nonenzymatic glycation of type I collagen on the migration of keratinocytes. The migration of keratinocytes was dramatically promoted on native type I collagen-coated dishes compared with that on uncoated dishes. When type I collagen was glycated with glycolaldehyde, large amounts of advanced glycation end products were produced; the glycated collagen I-coated dishes did not promote the migration of keratinocytes. Glycated collagen I did not affect the proliferative capacity of keratinocytes. However, the adhesion of keratinocytes to glycated collagen I was profoundly diminished in a glycation intensity-dependent manner. alpha2beta1 integrin is responsible for the migration and adhesion of keratinocytes to type I collagen. Pretreatment with glycated collagen I did not affect the expression level or functional activity of alpha2beta1 integrin on keratinocytes. These findings suggest that in the presence of glycated collagen I, keratinocytes lose their adhesive and migratory abilities. As the glycation did not modify the alpha2beta1 integrin on keratinocytes, it is suggested that glycation may diminish the binding capacity of type I collagen. 相似文献
3.
Gao HZ Kobayashi K Tabata A Tsuge H Iijima M Yasuda T Kalkanoglu HS Dursun A Tokatli A Coskun T Trefz FK Skladal D Mandel H Seidel J Kodama S Shirane S Ichida T Makino S Yoshino M Kang JH Mizuguchi M Barshop BA Fuchinoue S Seneca S Zeesman S Knerr I Rodés M Wasant P Yoshida I De Meirleir L Abdul Jalil M Begum L Horiuchi M Katunuma N Nakagawa S Saheki T 《Human mutation》2003,22(1):24-34
Classical citrullinemia (CTLN1), a rare autosomal recessive disorder, is caused by mutations of the argininosuccinate synthetase (ASS) gene, localized on chromosome 9q34.1. ASS functions as a rate-limiting enzyme in the urea cycle. Previously, we identified 32 mutations in the ASS gene of CTLN1 patients mainly in Japan and the United States, and to date 34 different mutations have been described in 50 families worldwide. In the present study, we report ASS mutations detected in 35 additional CTLN1 families from 11 countries. By analyzing the entire coding sequence and the intron-exon boundaries of the ASS gene using RT-PCR and/or genomic DNA-PCR, we have identified 16 novel mutations (two different 1-bp deletions, a 67-bp insertion, and 13 missense) and have detected 12 known mutations. Altogether, 50 different mutations (seven deletion, three splice site, one duplication, two nonsense, and 37 missense) in 85 CTLN1 families were identified. On the basis of primary sequence comparisons with the crystal structure of E. coli ASS protein, it may be concluded that any of the 37 missense mutations found at 30 different positions led to structural and functional impairments of the human ASS protein. It has been found that three mutations are particularly frequent: IVS6-2A>G in 23 families (Japan: 20 and Korea: three), G390R in 18 families (Turkey: six, U.S.: five, Spain: three, Israel: one, Austria: one, Canada: one, and Bolivia: one), and R304W in 10 families (Japan: nine and Turkey: one). Most mutations of the ASS gene are "private" and are distributed throughout the gene, except for exons 5 and 12-14. It seems that the clinical course of the patients with truncated mutations or the G390R mutation is early-onset/severe. The phenotype of the patients with certain missense mutations (G362V or W179R) is more late-onset/mild. Eight patients with R86H, A118T, R265H, or K310R mutations were adult/late-onset and four of them showed severe symptoms during pregnancy or postpartum. However, it is still difficult to prove the genotype-phenotype correlation, because many patients were compound heterozygotes (with two different mutations), lived in different environments at the time of diagnosis, and/or had several treatment regimes or various knowledge of the disease. 相似文献
4.
Seiko Iwata Yukiko Shibata Jun-ichi Kawada Shinya Hara Yukihiro Nishiyama Tsuneo Morishima Masaru Ihira Tetsushi Yoshikawa Yoshizo Asano Hiroshi Kimura 《Journal of clinical virology》2006,37(2):128-133
BACKGROUND: The loop-mediated isothermal amplification (LAMP) method is a novel technique for the amplification of specific DNA sequences. OBJECTIVES: To establish the LAMP method for amplifying Epstein-Barr virus (EBV) DNA and to examine its reliability for the detection of EBV DNA in clinical specimens. STUDY DESIGN: Sera from 108 patients, who were initially suspected of primary EBV infection, were tested by the EBV LAMP method, and the results were compared with those of the real-time PCR assay. Serological examination was regarded as the standard diagnostic method. RESULTS: To diagnose primary EBV infection, the sensitivity of LAMP was 86.4% and the specificity was 100%. The sensitivity of the real-time PCR assay was 84.1% and the specificity was 98.4%. Longitudinal analysis showed that the detection rate of EBV DNA in serum by the LAMP method decreased with time in accordance with the decrease of the EBV load. EBV DNA could not be detected in serum 40 days after onset of symptoms. CONCLUSIONS: These results indicate that the sensitivity and specificity of the LAMP method are comparable to those of real-time PCR and that detecting EBV DNA in serum by this method is potentially useful for diagnosing primary EBV infection. 相似文献
5.
Yoshino H Futakuchi M Cho YM Ogawa K Takeshita F Imai N Tamano S Shirai T 《Clinical & experimental metastasis》2005,22(5):441-447
Previously, we established the in vivo lung metastasis model of rat HCC induced by two hepatocarcinogens, diethylnitrosamine (DEN) and N-nitrosomorpholine (NMOR)
at a dose of 120 ppm. This model allows us to investigate modifying factors leading to the inhibition of metastasis formation.
However, low survival rates made the evaluation of metastasis formation difficult. The current experiments were conducted
to modify the experimental protocol to improve survival and to establish a better animal metastasis model. Lower doses of
NMOR (80 or 40 ppm in drinking water) were given to F344 rats for 14 weeks after DEN treatment. Survival rates in the 80 ppm
group and in the 40 ppm group were 57% and 81%, respectively and these values were significantly higher than that in 120 ppm.
Incidences of lung metastasis in the 40 ppm group steadily increased up to 67% by week 36 while that in the 80 ppm increased
sharply up to 86% by week 24. Severity of lung metastases in the 40 ppm group at week 36 was mild compared with the 80 ppm
group at week 24. In the second experiment, in order to characterize HCC development and lung metastasis in the 40 ppm group,
rats given DEN and then followed with 40 ppm NMOR were killed sequentially. Development of HCC was observed at week 14 and
reached 100% incidence at week 20. First lung metastatic lesions were evident at week 22, and incidence of lung metastasis
reached 100%. Tumor cells were identified in the blood at week 20 by RT-PCR. The current study revealed that 40 ppm NMOR for
14 weeks after DEN treatment developed HCC without lung metastases at week 22, then HCC with a frequent lung metastasis at
week 40. Thus, it can be said that this system is a more appropriate model for elucidation of mechanisms of metastasis and
also for analysis of factors to inhibit natural metastasis. 相似文献
6.
Tsuda Hiroyuki; Sakata Takao; Tamano Seiko; Okumara Masanao; Ito Nobuyuki 《Carcinogenesis》1983,4(5):523-528
Sequential observations were carried out on the induction ofpreneoplastic lesions in the liver and the kidney. Rats wereinitially given N-ethyl-N-hydroxyethylnitrosamine (EHEN) intheir drinking water (0.1%) for 3 days (Group 1), 1 week (Group2) or 2 weeks (Group 3) or tap water (Group 4). Rats in Groups1 3 were subjected to partial hepatectomy and unilateralnephrectomy (right side) 2 weeks after the end of EHEN treatment.Rats from these groups were killed in week 10, 20, 30 and 40of the experiment. In the liver, the effect of EHEN in the inductionof -glutamyltranspeptidase (-GT) positive foci and hyperplasticnodules (HN) was clearly dependent on the length of treatment.The preneoplastic lesions increased with the lapse of observationtime. Changes measured as number of -GT positive foci were 1040times greater than those measured as HN, especially among thesmall size range. Values for changes in Group 1 given 0.1% EHENfor 3 days were very low, indicating that this dose is closeto the threshold. Two rats with hepatocellular carcinoma inGroup 3 given EHEN for 2 weeks survived until week 40. In thekidney, tubular epithelial proliferations composed of cellswith slightly basophilic cytoplasm and slightly atypical nucleiwere tentatively named atypical cell foci (ACF). EHEN inducedACF, renal cell adenomas and renal cell carcinomas. The increasein the induction of ACF was dependent on the length of observationperiod but not on the length of treatment. Even though controlrats (not treated with EHEN) also had ACF, their quantitativevalues were far less than the groups given EHEN and killed atweek 40, indicating that a large number of ACF were inducedby EHEN. Therefore, EHEN is good for experimental inductionof preneoplastic lesions in the liver and kidney of rats. Theexperimental schedule for Groups 1 and 2 could be used as ashort-term screening test for promoters and the schedule forGroup 3 as an assay for inhibitors. 相似文献
7.
Norio Imai Mayumi Kawabe Seiko Tamano Yuko Doi Hironao Nakashima Mayuko Suguro Takamasa Numano Tomomi Hara Akihiro Hagiwara Fumio Furukawa Yoshihisa Kaneda Norifumi Tateishi Wataru Fujii Hiroshi Kawashima Hiroshi Shibata Yutaka Sakakibara 《Food and chemical toxicology》2012
The modifying potential on tumor development of arachidonate-enriched triglyceride oil (ARA-oil) containing approximately 40% arachidonic acid was investigated in a medium-term multi-organ carcinogenesis bioassay using male and female F344 rats. The animals were sequentially given five carcinogens with different target sites in the first 4 weeks, and then administered ARA-oil for 24 weeks at dietary levels of 0% (control), 1.25%, 2.5% or 5.0%. No statistically significant differences in incidences and multiplicities of hyperplastic and neoplastic lesions were showed in the large intestine in either sex. In the liver, kidney, and lung in both sexes, and the mammary gland and uterus in females, tumor promoting potential was not evident with ARA-oil treatment. ARA-oil did not affect the quantitative data for glutathione S-transferase placental form positive foci of the liver. Increased induction of hyperplastic or neoplastic lesions in the urinary bladder and thyroid in ARA-oil-treated groups was without dose dependence. In addition, a second experiment with ARA-oil only administration for 8-week revealed no effects on cellular proliferation in the urinary bladder or thyroid in either sex. These results indicate that ARA-oil has no tumor promoting potential in any organs or tissues initiated with the five carcinogens applied in the present study. 相似文献
8.
9.
The bridge treatment selected at the decision for transplantation did not affect the outcomes in patients with MDS
下载免费PDF全文
![点击此处可从《Hematological oncology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Shinichi Kako Yoshinobu Kanda Jun Kato Wataru Yamamoto Seiko Kato Makoto Onizuka Akira Yokota Raine Tatara Hiroki Yokoyama Maki Hagihara Kensuke Usuki Moritaka Gotoh Reiko Watanabe Nobutaka Kawai Takayuki Saitoh Heiwa Kanamori Satoshi Takahashi Shinichiro Okamoto 《Hematological oncology》2017,35(3):341-349
The optimal treatment for use as a bridge to allogeneic hematopoietic stem cell transplantation at the decision for transplantation has not been established in patients with myelodysplastic syndrome (MDS). We retrospectively evaluated the clinical outcomes after the decision for transplantation in our patients with MDS or acute myeloid leukemia (AML) secondary to MDS, aged more than 15 years, who underwent transplantation between 2007 and 2012. A total of 124 patients were included. We classified patients into two groups according to the bridge treatment selected at the decision for transplantation: Group 1, supportive care (n = 79), immunosuppressive therapy (n = 7), low‐dose chemotherapy (n = 12); Group 2, AML‐type induction chemotherapy (ICT: n = 22), azacitidine (Aza: n = 4). The rate of blasts in the bone marrow significantly influenced the treatment selection at the time of decision. There was no significant difference between the two groups in the rate of overall survival (OS) from the decision (73.1% vs 80.4% at 1 year) or from transplantation (59.0% vs 59.2% at 1 year). A significant difference was not observed even after patients were stratified according to either the rate of blasts in the bone marrow at the time of decision or the propensity score. In conclusion, the bridge treatment selected at the decision for transplantation did not affect the outcomes of transplantation in patients with MDS. However, this analysis did not include patients who could not undergo transplantation after the decision, and thus a prospective study is warranted. Copyright © 2015 John Wiley & Sons, Ltd. 相似文献
10.
Two cases of Japanese spotted fever infected in Rokko mountain near urban area of southern Hyogo Prefecture
下载免费PDF全文
![点击此处可从《The Journal of dermatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)